Segal Jeffrey 4
4 · INVO Bioscience, Inc. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Segal Jeffrey
Director
Transactions
- Award
Stock Option
2022-01-15+9,762→ 9,762 totalExercise: $3.61Exp: 2032-01-14→ Common Stock (9,762 underlying) - Award
Common Stock
2022-01-15+8,034→ 18,009 total
Footnotes (1)
- [F1]The stock option vests in monthly increments over a period of twelve months from the date of grant.